PO-1242 Clinical, pathological and dosimetric factors influencing outcomes in NSCLC treated with SABR. - Padden-Modi, M.; Spivak, Y.; Gleeson, I.; Robinson, A.; Thippu Jayaprakash, K. (Radiotherapy & Oncology, 2022)